Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Licochalcone A inhibits EGFR signalling and translationally suppresses survivin expression in human cancer cells
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 25, Issue 2, Pages 813-826
Publisher
Wiley
Online
2020-11-28
DOI
10.1111/jcmm.16135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
- (2019) Gillianne G.Y. Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin promotes survivin degradation through AMPK/PKA/GSK-3β-axis in non-small cell lung cancer
- (2019) Zhuang Luo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC
- (2019) Paola Bordi et al. LUNG CANCER
- Differential effects of adjuvant EGFR tyrosine kinase inhibitors in patients with different stages of non-small-cell lung cancer after radical resection: an updated meta-analysis
- (2019) Di Lu et al. Cancer Management and Research
- Role of Smac, survivin, XIAP, and Omi/HtrA2 proteins in determining the chemotherapeutic response of patients with cervical cancer treated with neoadjuvant chemotherapy
- (2019) Tianyi Ye et al. Cancer Biomarkers
- Systematic review and network meta-analysis of first-line therapy for advanced EGFR-positive non-small-cell lung cancer
- (2019) Jacob Franek et al. Future Oncology
- Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer
- (2019) Yücel Başpınar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
- (2019) Xiaojiaoyang Li et al. PHARMACOLOGICAL RESEARCH
- Licochalcone A inhibits cell proliferation, migration, and invasion through regulating the PI3K/AKT signaling pathway in oral squamous cell carcinoma
- (2019) Yuli Hao et al. OncoTargets and Therapy
- MicroRNA-218 regulates the chemo-sensitivity of cervical cancer cells through targeting survivin
- (2019) Minmin Yu et al. Cancer Management and Research
- Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma
- (2019) Li Zhang et al. Annals of Translational Medicine
- Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
- (2019) TOMOMI SANOMACHI et al. ANTICANCER RESEARCH
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- Optimizing outcomes and treatment sequences in EGFR mutation-positive non-small-cell lung cancer: recent updates
- (2019) Nicolas Girard Future Oncology
- Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
- (2019) Fengzhi Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study
- (2019) Samaneh Reiszadeh-Jahromi et al. NEUROCHEMICAL RESEARCH
- Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?
- (2019) Sanjal Desai et al. Current Oncology Reports
- The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models
- (2019) David Martínez-García et al. Biomolecules
- Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
- (2019) Camille Mehlman et al. LUNG CANCER
- Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
- (2019) Ana C.Z. Gelatti et al. LUNG CANCER
- Acquired resistance in oncogene-addicted non-small-cell lung cancer
- (2018) Claudio Sini et al. Future Oncology
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of survivin enhances radiosensitivity of esophageal cancer cells by switching radiation-induced senescence to apoptosis
- (2018) Xianghe Liu et al. OncoTargets and Therapy
- Repression of Noxa by Bmi1 contributes to deguelin-induced apoptosis in non-small cell lung cancer cells
- (2018) Wei Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Biological Effects Of Licochalcones
- (2018) Daniela Maria Pia Gatta et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
- (2018) Gonzalo Recondo et al. Nature Reviews Clinical Oncology
- Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells via p53 Activation and Down-regulation of Survivin
- (2018) PREEYAPORN PLAIMEE PHIBOONCHAIYANAN et al. ANTICANCER RESEARCH
- Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway
- (2017) Wei Li et al. Cancer Medicine
- Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis
- (2016) Liang Duan et al. BMC CANCER
- AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
- (2015) Pasi A. Jänne et al. NEW ENGLAND JOURNAL OF MEDICINE
- 3,6,2′,4′,5′-Pentahydroxyflavone, an Orally Bioavailable Multiple Protein Kinase Inhibitor, Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer
- (2014) Yuqiao Sheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- Guanylate cyclase activator YC-1 potentiates apoptotic effect of licochalcone A on human epithelial ovarian carcinoma cells via activation of death receptor and mitochondrial pathways
- (2012) Chung Soo Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2012) Chunguang Li et al. PLoS One
- Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
- (2009) Uta B. Hofmann et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Licorice and Licochalcone-A Induce Autophagy in LNCaP Prostate Cancer Cells by Suppression of Bcl-2 Expression and the mTOR Pathway
- (2009) Yi-Te Yo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started